By proceeding, you agree to our Terms of Use and Privacy Policy.
Cecile Geuijen is currently working as the Chief Scientific Officer at Merus N.V. which he joined as a Senior Scientist in 2011. Prior to that, he was a Senior Scientist with Genmab and Crucell.
Talks About #Oncology
Preferred Locations #Europe
The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine.
